Brief: Sharps Technology Provides Update On Commercialization Activities And Is Highlighted In Med Tech Outlook Feature Article

Skyai

06/07/2023 13:00

July 6 (Reuters) - Sharps Technology Inc  STSS.O :
    * SHARPS TECHNOLOGY PROVIDES UPDATE ON COMMERCIALIZATION
ACTIVITIES AND IS HIGHLIGHTED IN MED TECH OUTLOOK FEATURE
ARTICLE
    * SHARPS TECHNOLOGY-PRODUCTION OF PREFILLED SYRINGE PRODUCTS
WILL
BEGIN IN Q4 OF 2023 TO SUPPORT CO-MANUFACTURING AGREEMENT WITH
NEPHRON PHARMACEUTICALS
    * SHARPS TECHNOLOGY - ENTERED INTO AGREEMENT WITH A MAJOR
MEDICAL
DEVICE CO
    * SHARPS TECHNOLOGY INC - SPECIALTY POLYMER-BASED PREFILLED
PRODUCTS WILL BE MANUFACTURED IN U.S. AT NEPHRON'S FACILITY IN
COLUMBIA, SOUTH CAROLINA
    * SHARPS - DEAL TO BEGIN WITH 1ML AND 3ML SECUREGARD PRODUCT
LINE,
TO BE FOLLOWED BY SOLOGARD® VIAL-DRAW PRODUCTS FOR LARGER VOLUME
DRUG APPLICATIONS
    * SHARPS TECHNOLOGY-AGREEMENT WITH MEDICAL DEVICE CO TO
BEGIN
QUALIFICATION PROCESS FOR SMART SAFETY SYRINGE TECHNOLOGY

Source text for Eikon:  ID:nGNX2B0pZj 
Further company coverage:  STSS.O 

 ((reuters.briefs@thomsonreuters.com;))